CAS No.:97-64-3

TOXICITY DATA with REFERENCE：

 

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
guinea pig	LDLo	intramuscular	2605mg/kg (2605mg/kg)	LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Journal of Pharmacology and Experimental Therapeutics. Vol. 76, Pg. 189, 1942.
mouse	LD50	intravenous	600mg/kg (600mg/kg)		Journal of Pharmacology and Experimental Therapeutics. Vol. 65, Pg. 89, 1939.
mouse	LD50	oral	2500mg/kg (2500mg/kg)		Journal of Pharmacology and Experimental Therapeutics. Vol. 65, Pg. 89, 1939.
mouse	LD50	subcutaneous	2500mg/kg (2500mg/kg)		Journal of Pharmacology and Experimental Therapeutics. Vol. 65, Pg. 89, 1939.
rabbit	LD50	skin	> 5gm/kg (5000mg/kg)		Food and Chemical Toxicology. Vol. 20, Pg. 677, 1982.
rat	LD50	oral	8200mg/kg (8200mg/kg)		International Journal of Toxicology. Vol. 17(Suppl,
rat	LDLo	intraperitoneal	1gm/kg (1000mg/kg)	BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Journal of Pharmacy and Pharmacology. Vol. 11, Pg. 150, 1959.

Consensus Reports：

 

SAFETY PROFILE：

Hazard Codes: Xi
Risk Statements: 10-37-41 
R10:Flammable. 
R37:Irritating to respiratory system 
R41:Risk of serious damage to the eyes.
Safety Statements: 24-26-39 
S24:Avoid contact with skin. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S39:Wear eye / face protection.
RIDADR: 1192
RTECS: OD5075000
HazardClass: 3.2
PackingGroup: III

Standards and Recommendations：

 

Analytical Methods：